Contribute
España
Italia
대한민국
日本
Français
Benzinga
Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
761.130.03%
QQQ
709.610.06%
BTC/USD
77423.880.9827%
DIA
524.660.03%
GLD
393.070.06%
TLT
80.93-

Addus HomeCare Corp

ADUSNASDAQ
Trade with Public
Trade with Public
$117.33
0.240.2%
At close: Sep 14, 5:00 PM EST
$118.10
0.770.66%
After Hours: 5:50 PM EST
M&A: AccentCare announced it will sell assets to Addus HomeCare (ADUS) on Monday, September 14, 2026 for $275M
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareOptionsStock Report

Addus HomeCare Analyst Price Targets

Wall Street analyst price targets and consensus rating for Addus HomeCare (ADUS).

Price Target Range — 12 Quarters

Analyst Consensus — 13 Analysts

2S.Buy
8Buy
2Hold
1Sell
Consensus RatingOverweight# Analysts13Avg. Consensus PT$138Upside to Avg. PT+16.4%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →
DateFirmAnalystActionRating ChangePrice Target
Sep 14, 2026B of A SecuritiesJoanna GajukDowngradeBuy→Neutral$140→$125
Aug 5, 2026RBC CapitalBen HendrixPT RaiseOutperform$130→$134
More with Benzinga EdgeGet Access

Analyst Ratings News

This Charter Communications Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday

Analysts downgraded ADUS, HPE, ERII, CHTR and CCI; targets fell for ADUS and CCI, while CHTR received a $118 target.
Avi Kapoor

PRO
B of A Securities Downgrades Addus HomeCare to Neutral, Lowers Price Target to $125

B of A Securities analyst Joanna Gajuk downgrades Addus HomeCare (NASDAQ:ADUS) from Buy to Neutral and lowers the price target from $140 to $125.
Benzinga Newsdesk

PRO
RBC Capital Maintains Outperform on Addus HomeCare, Raises Price Target to $134

RBC Capital analyst Ben Hendrix maintains Addus HomeCare (NASDAQ:ADUS) with a Outperform and raises the price target from $130 to $134.
Benzinga Newsdesk

PRO
Barclays Maintains Underweight on Addus HomeCare, Raises Price Target to $96

Barclays analyst Andrew Mok maintains Addus HomeCare (NASDAQ:ADUS) with a Underweight and raises the price target from $92 to $96.
Benzinga Newsdesk

PRO
Citizens Reiterates Market Outperform on Addus HomeCare, Maintains $142 Price Target

Citizens analyst Constantine Davides reiterates Addus HomeCare (NASDAQ:ADUS) with a Market Outperform and maintains $142 price target.
Benzinga Newsdesk

PRO
Barclays Maintains Underweight on Addus HomeCare, Lowers Price Target to $92

Barclays analyst Andrew Mok maintains Addus HomeCare (NASDAQ:ADUS) with a Underweight and lowers the price target from $102 to $92.
Benzinga Newsdesk

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved